{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:49:39Z","timestamp":1793051379973,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009633","name":"U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["K23HD10165"],"award-info":[{"award-number":["K23HD10165"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To describe common pulmonary vasodilators (PV), exposure timing, and characteristics associated with their use in very preterm (VP) infants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study design<\/jats:title>\n                    <jats:p>Observational study of VP infants discharged from U.S. children\u2019s hospitals (2011\u20132021). PV exposures during hospitalization were identified, and multivariable modeling determined characteristics associated with exposure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 37,428 infants, 6.3% received PV. Early inhaled nitric oxide (iNO) and late sildenafil were most common. Early exposure was associated with lower gestational age, aOR: 9.2 (7.3\u201311.7), 22\u201325 vs. 29\u201331 weeks) and small for gestational age (SGA), 2.3 (2.0\u20132.7). Late exposure was associated with bronchopulmonary dysplasia (BPD) grade, 26.2 (16.8\u201340.9), grade 3 vs. no BPD) and early PV exposure, 3.7 (2.9\u20134.8).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Early iNO and late sildenafil are used in VP infants despite limited evidence. Prospective early studies enrolling extremely preterm and SGA infants and late studies enrolling infants with early PV exposure and high-grade BPD would target current evidence gaps.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41372-025-02309-x","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T08:01:39Z","timestamp":1746172899000},"page":"1382-1388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pulmonary vasodilator use in very preterm infants in United States children\u2019s hospitals"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1083-6329","authenticated-orcid":false,"given":"Tomas F.","family":"Vega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9179-8032","authenticated-orcid":false,"given":"Erik A.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2354-5447","authenticated-orcid":false,"given":"Catherine M.","family":"Avitabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Lorch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6023-1634","authenticated-orcid":false,"given":"Michael L.","family":"O\u2019Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6427-093X","authenticated-orcid":false,"given":"Nicolas A.","family":"Bamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"2309_CR1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S2352-4642(21)00311-4","volume":"6","author":"J Perin","year":"2022","unstructured":"Perin J, Mulick A, Yeung D, Villavicencio F, Lopez G, Strong KL, et al. Global, regional, and national causes of under-5 mortality in 2000\u201319: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet Child Adolesc Health. 2022;6:106\u201315.","journal-title":"Lancet Child Adolesc Health"},{"key":"2309_CR2","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1001\/jama.2015.10244","volume":"314","author":"BJ Stoll","year":"2015","unstructured":"Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, et al. Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. JAMA. 2015;314:1039\u201351.","journal-title":"JAMA"},{"key":"2309_CR3","doi-asserted-by":"publisher","first-page":"103.e1","DOI":"10.1016\/j.ajog.2016.01.004","volume":"215","author":"TA Manuck","year":"2016","unstructured":"Manuck TA, Rice MM, Bailit JL, Grobman WA, Reddy UM, Wapner RJ, et al. Preterm Neonatal Morbidity and Mortality by Gestational Age: A Contemporary Cohort. Am J Obstet Gynecol. 2016;215:103.e1.","journal-title":"Am J Obstet Gynecol"},{"key":"2309_CR4","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41390-020-0993-4","volume":"89","author":"G Hansmann","year":"2021","unstructured":"Hansmann G, Sallmon H, Roehr CC, Kourembanas S, Austin ED. Koestenberger M. Pulmonary hypertension in bronchopulmonary dysplasia. Pediatr Res. 2021;89:446\u201355.","journal-title":"Pediatr Res"},{"key":"2309_CR5","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1542\/peds.2007-0971","volume":"120","author":"E Khemani","year":"2007","unstructured":"Khemani E, McElhinney DB, Rhein L, Andradeb O, Lacro RV, Thomas KC, et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics. 2007;120:1260\u20139.","journal-title":"Pediatrics"},{"key":"2309_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41372-018-0303-8","volume":"39","author":"G Altit","year":"2019","unstructured":"Altit G, Bhombal S, Hopper RK, Tacy TA, Feinstein J. Death or resolution: the \u201cnatural history\u201d of pulmonary hypertension in bronchopulmonary dysplasia. J Perinatol. 2019;39:415\u201325.","journal-title":"J Perinatol"},{"key":"2309_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jpeds.2019.04.046","volume":"211","author":"MS Ong","year":"2019","unstructured":"Ong MS, Abman S, Austin ED, Feinstein JA, Hopper RK, Krishnan US, et al. Racial and Ethnic Differences in Pediatric Pulmonary Hypertension: An Analysis of the Pediatric Pulmonary Hypertension Network Registry. J Pediatr. 2019;211:63\u201371.e6.","journal-title":"J Pediatr"},{"key":"2309_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/archdischild-2019-318531","volume":"106","author":"S Arjaans","year":"2021","unstructured":"Arjaans S, Haarman MG, Roofthooft MTR, Fries MWF, Kooi EMW, Bos AF, et al. Fate of pulmonary hypertension associated with bronchopulmonary dysplasia beyond 36 weeks postmenstrual age. Arch Dis Child Fetal Neonatal Ed. 2021;106:45\u201350.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2309_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000516107","volume":"118","author":"SH Abman","year":"2021","unstructured":"Abman SH. Pulmonary Hypertension: The Hidden Danger for Newborns. Neonatology. 2021;118:211\u20137.","journal-title":"Neonatology"},{"key":"2309_CR10","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1002\/ppul.25602","volume":"56","author":"KW Malloy","year":"2021","unstructured":"Malloy KW, Austin ED. Pulmonary hypertension in the child with bronchopulmonary dysplasia. Pediatr Pulmonol. 2021;56:3546\u201356.","journal-title":"Pediatr Pulmonol"},{"key":"2309_CR11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jpeds.2018.07.035","volume":"203","author":"JM Lagatta","year":"2018","unstructured":"Lagatta JM, Hysinger EB, Zaniletti I, Wymore EM, Vyas-Read S, Yallapragada S, et al. The Impact of Pulmonary Hypertension in Preterm Infants with Severe Bronchopulmonary Dysplasia through 1 Year. J Pediatrics. 2018;203:218\u201324.e3.","journal-title":"J Pediatrics"},{"key":"2309_CR12","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1055\/s-0035-1571201","volume":"33","author":"NL Swier","year":"2016","unstructured":"Swier NL, Richards B, Cua CL, Lynch SK, Yin H, Nelin LD, et al. Pulmonary Vein Stenosis in Neonates with Severe Bronchopulmonary Dysplasia. Am J Perinatol. 2016;33:671\u20137.","journal-title":"Am J Perinatol"},{"key":"2309_CR13","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","volume":"132","author":"SH Abman","year":"2015","unstructured":"Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, et al. Pediatric pulmonary hypertension. Circulation. 2015;132:2037\u201399.","journal-title":"Circulation"},{"key":"2309_CR14","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.healun.2019.06.022","volume":"38","author":"G Hansmann","year":"2019","unstructured":"Hansmann G, Koestenberger M, Alastalo TP, Apitz C, Austin ED, Bonnet D, et al. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT. J Heart Lung Transplant. 2019;38:879\u2013901.","journal-title":"J Heart Lung Transplant"},{"key":"2309_CR15","doi-asserted-by":"crossref","unstructured":"Abman SH, Mullen MP, Sleeper LA, Austin ED, Rosenzweig EB, Kinsella JP, et al. Characterisation of paediatric pulmonary hypertensive vascular disease from the PPHNet Registry. Eur Respir J. 2021;59:2003337.","DOI":"10.1183\/13993003.03337-2020"},{"key":"2309_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jpeds.2017.05.029","volume":"188","author":"U Krishnan","year":"2017","unstructured":"Krishnan U, Feinstein JA, Adatia I, Austin ED, Mullen MP, Hopper RK, et al. Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary Dysplasia. J Pediatrics. 2017;188:24\u201334.e1.","journal-title":"J Pediatrics"},{"key":"2309_CR17","doi-asserted-by":"crossref","unstructured":"Collaco JM, Abman SH, Austin ED, Avitabile CM, Bates A, Fineman JR, et al. Kids Mod PAH trial: A multicenter trial comparing mono\u2010 versus duo\u2010therapy for initial treatment of pediatric pulmonary hypertension. Pulm Circ. 2023;13:e12305.","DOI":"10.1002\/pul2.12305"},{"key":"2309_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jpeds.2016.10.082","volume":"181","author":"SH Abman","year":"2017","unstructured":"Abman SH, Collaco JM, Shepherd EG, Keszler M, Cuevas-Guaman M, Welty SE, et al. Interdisciplinary Care of Children with Severe Bronchopulmonary Dysplasia. J Pediatrics. 2017;181:12\u201328.e1.","journal-title":"J Pediatrics"},{"key":"2309_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jpeds.2017.11.027","volume":"195","author":"JD Awerbach","year":"2018","unstructured":"Awerbach JD, Mallory GB, Kim S, Cabrera AG. Hospital Readmissions in Children with Pulmonary Hypertension: A Multi-Institutional Analysis. J Pediatrics. 2018;195:95\u2013101.e4.","journal-title":"J Pediatrics"},{"key":"2309_CR20","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/s41372-019-0415-9","volume":"39","author":"NA Bamat","year":"2019","unstructured":"Bamat NA, Kirpalani H, Feudtner C, Jensen EA, Laughon MM, Zhang H, et al. Medication use in infants with severe bronchopulmonary dysplasia admitted to United States children\u2019s hospitals. J Perinatol. 2019;39:1291\u20139.","journal-title":"J Perinatol"},{"key":"2309_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jpeds.2020.10.073","volume":"231","author":"NA Bamat","year":"2021","unstructured":"Bamat NA, Nelin TD, Eichenwald EC, Kirpalani H, Laughon MM, Jackson WM, et al. Loop Diuretics in Severe Bronchopulmonary Dysplasia: Cumulative Use and Associations with Mortality and Age at Discharge. J Pediatr. 2021;231:43\u20139.e3.","journal-title":"J Pediatr"},{"key":"2309_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1542\/hpeds.2015-0076","volume":"6","author":"CH Backes","year":"2016","unstructured":"Backes CH, Reagan PB, Smith CV, Jadcherla SR, Slaughter JL. Sildenafil Treatment of Infants With Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension. Hosp Pediatr. 2016;6:27\u201333.","journal-title":"Hosp Pediatr"},{"key":"2309_CR23","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/ppul.24592","volume":"55","author":"JM Greenberg","year":"2020","unstructured":"Greenberg JM, Poindexter BB, Shaw PA, Bellamy SL, Keller RL, Moore PE, et al. Respiratory medication use in extremely premature (<29 weeks) infants during initial NICU hospitalization: Results from the prematurity and respiratory outcomes program. Pediatr Pulmonol. 2020;55:360\u20138.","journal-title":"Pediatr Pulmonol."},{"key":"2309_CR24","doi-asserted-by":"publisher","first-page":"e945","DOI":"10.1542\/peds.2011-1809","volume":"129","author":"MR Stenger","year":"2012","unstructured":"Stenger MR, Slaughter JL, Kelleher K, Shepherd EG, Klebanoff MA, Reagan P, et al. Hospital variation in nitric oxide use for premature infants. Pediatrics. 2012;129:e945\u201351.","journal-title":"Pediatrics"},{"key":"2309_CR25","doi-asserted-by":"crossref","unstructured":"Laas E, Lelong N, Thieulin AC, Houyel L, Bonnet D, Ancel PY, et al. Preterm birth and congenital heart defects: a population-based study. Pediatrics. 2012;130:e829\u201337.","DOI":"10.1542\/peds.2011-3279"},{"key":"2309_CR26","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1164\/rccm.201812-2348OC","volume":"200","author":"EA Jensen","year":"2019","unstructured":"Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M, et al. The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants An Evidence-based Approach. Am J Respir Crit Care Med. 2019;200:751\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"2309_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2431-13-59","volume":"13","author":"TR Fenton","year":"2013","unstructured":"Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013;13:1\u201313.","journal-title":"BMC Pediatr"},{"key":"2309_CR28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1017\/S1047951110001745","volume":"21","author":"T Humpl","year":"2011","unstructured":"Humpl T, Reyes JT, Erickson S, Armano R, Holtby H, Adatia I. Sildenafil therapy for neonatal and childhood pulmonary hypertensive vascular disease. Cardiol Young. 2011;21:187\u201393.","journal-title":"Cardiol Young"},{"key":"2309_CR29","doi-asserted-by":"crossref","unstructured":"Mourani PM, Sontag MK, Ivy DD, Abman SH. Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease. J Pediatr. 2009;154:379\u201384.","DOI":"10.1016\/j.jpeds.2008.09.021"},{"key":"2309_CR30","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1136\/archdischild-2012-303333","volume":"98","author":"AJ Wardle","year":"2013","unstructured":"Wardle AJ, Wardle R, Luyt K, Tulloh R. The utility of sildenafil in pulmonary hypertension: a focus on bronchopulmonary dysplasia. Arch Dis Child. 2013;98:613\u20137.","journal-title":"Arch Dis Child"},{"key":"2309_CR31","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1542\/peds.2005-0523","volume":"117","author":"H Baquero","year":"2006","unstructured":"Baquero H, Soliz A, Neira F, Venegas ME, Sola A. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics. 2006;117:1077\u201383.","journal-title":"Pediatrics"},{"key":"2309_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12887-020-02453-7","volume":"20","author":"S Schneider","year":"2020","unstructured":"Schneider S, Bailey M, Spears T, Esther CR, Laughon MM, Hornik CP, et al. Safety of sildenafil in premature infants with severe bronchopulmonary dysplasia (SILDI-SAFE): a multicenter, randomized, placebo-controlled, sequential dose-escalating, double-masked, safety study. BMC Pediatr. 2020;20:1\u20139.","journal-title":"BMC Pediatr"},{"key":"2309_CR33","doi-asserted-by":"crossref","unstructured":"Lang JE, Hornik CD, Martz K, Jacangelo J, Anand R, Greenberg R, et al. Safety of sildenafil in premature infants at risk of bronchopulmonary dysplasia: Rationale and methods of a phase II randomized trial. Contemp Clin Trials Commun. 2022;30:101025.","DOI":"10.1016\/j.conctc.2022.101025"},{"key":"2309_CR34","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/jamapediatrics.2017.2618","volume":"171","author":"SU Hasan","year":"2017","unstructured":"Hasan SU, Potenziano J, Konduri GG, Perez JA, Van Meurs KP, Walker MW, et al. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial. JAMA Pediatr. 2017;171:1081\u20139.","journal-title":"JAMA Pediatr"},{"key":"2309_CR35","doi-asserted-by":"crossref","unstructured":"Barrington KJ, Finer N, Pennaforte T. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev. 2017;1:CD000509.","DOI":"10.1002\/14651858.CD000509.pub5"},{"key":"2309_CR36","doi-asserted-by":"crossref","unstructured":"Barrington KJ, Finer N, Pennaforte T, Altit G. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev. 2017;1:CD000399.","DOI":"10.1002\/14651858.CD000399.pub3"},{"key":"2309_CR37","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1055\/s-0038-1667378","volume":"36","author":"EJ Thompson","year":"2019","unstructured":"Thompson EJ, Perez K, Hornik CP, Smith PB, Clark RH, Laughon M. Sildenafil Exposure in the Neonatal Intensive Care Unit. Am J Perinatol. 2019;36:262.","journal-title":"Am J Perinatol"},{"key":"2309_CR38","doi-asserted-by":"crossref","unstructured":"van der Graaf M, Rojer LA, Helbing WA, Reiss IKM, Etnel JRG, Bartelds B. Sildenafil for bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis. Pulm Circ. 2019;9:2045894019837875.","DOI":"10.1177\/2045894019837875"},{"key":"2309_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41372-021-01261-w","volume":"42","author":"W Jackson","year":"2021","unstructured":"Jackson W, Gonzalez D, Smith PB, Ambalavanan N, Atz AM, Sokol GM, et al. Safety of sildenafil in extremely premature infants: a phase I trial. J Perinatol. 2021;42:31\u20136.","journal-title":"J Perinatol"},{"key":"2309_CR40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1164\/rccm.201409-1594OC","volume":"191","author":"PM Mourani","year":"2015","unstructured":"Mourani PM, Sontag MK, Younoszai A, Miller JI, Kinsella JP, Baker CD, et al. Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2015;191:87\u201395.","journal-title":"Am J Respir Crit Care Med"},{"key":"2309_CR41","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jpeds.2022.07.039","volume":"251","author":"S Arjaans","year":"2022","unstructured":"Arjaans S, Fries MWF, Schoots MH, Schilte CFM, Roofthooft MTR, Vrijlandt EJLE, et al. Clinical Significance of Early Pulmonary Hypertension in Preterm Infants. J Pediatr. 2022;251:74\u201381.e3.","journal-title":"J Pediatr"},{"key":"2309_CR42","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1001\/jamapediatrics.2022.2663","volume":"176","author":"TR Lewis","year":"2022","unstructured":"Lewis TR, Kielt MJ, Walker VP, Levin JC, Guaman MC, Panitch HB, et al. Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia. JAMA Pediatr. 2022;176:852\u20139. https:\/\/doi.org\/10.1001\/jamapediatrics.2022.2663.","journal-title":"JAMA Pediatr"},{"key":"2309_CR43","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.025784","volume":"11","author":"CH Backes","year":"2022","unstructured":"Backes CH, Hill KD, Shelton EL, Slaughter JL, Lewis TR, Weisz DE, et al. Patent Ductus Arteriosus: A Contemporary Perspective for the Pediatric and Adult Cardiac Care Provider. J Am Heart Assoc. 2022 ;11:e025784. https:\/\/doi.org\/10.1161\/JAHA.122.025784.","journal-title":"J Am Heart Assoc"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41372-025-02309-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-025-02309-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-025-02309-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T11:09:12Z","timestamp":1759144152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-025-02309-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2309"],"URL":"https:\/\/doi.org\/10.1038\/s41372-025-02309-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5492163\/v1","asserted-by":"object"}]},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research used observational data that is considered exempt from review by the Institutional Review Board as it relies on existing data obtained in such a manner that subjects cannot be identified. Therefore, an ethics statement is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}